Pantoprazole for symptoms of infant GERD: The emperor has no clothes!

Journal of Pediatric Gastroenterology and Nutrition

Volumn 51, Issue 4, 2010, Pages 537-

  Orenstein, Susan R ^a   Hassall, Eric ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE; PANTOPRAZOLE; PLACEBO; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; PROTON PUMP INHIBITOR;

CLINICAL TRIAL; DRUG EFFICACY; GASTROESOPHAGEAL REFLUX; HUMAN; LETTER; OPEN STUDY; PARALLEL DESIGN; POST HOC ANALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; SHORT COURSE THERAPY; STATISTICAL ANALYSIS; INFANT; NEWBORN; NOTE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCIBILITY; TREATMENT OUTCOME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; GASTROESOPHAGEAL REFLUX; HUMANS; INFANT; INFANT, NEWBORN; PROTON PUMP INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 78449264343     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181f79600     Document Type: Letter

References (5)

1. Winter H, Kum-Nji P, Mahomedy SH, et al. Efficacy and safety of pantoprazole delayed-release granules for oral suspension in a acebocontrolled treatment-withdrawal study in infants 1-11 months old with symptomatic GERD. J Pediatr Gastroenterol Nutr 010;50:609-18.
2. Orenstein SR, Hassall E, Furmaga-Jablonska W, et al. Multicenter double-blind, randomized, placebo-controlled trial assessing efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. J Pediatr 2009;154:514-20.
3. Orenstein SR, Hassall E, Furmaga-Jablonska W, et al. Multicenter, double-blind, randomized, placebo-controlled trial assessing efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. Paper presented at 21st Annual Meeting of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition, San Diego, CA; November 13-15, 2008.
4. Vandenplas Y, Rudolph CD, Di Lorenzo C, et al. Pediatric gastroesophageal reflux clinical practice guidelines: Joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr 2009;49:498-547.
5. Orenstein SR, Hassall E. Infants and proton pump inhibitors: Tribulations, no trials. J Pediatr Gastroenterol Nutr 2007;45:395-8.